Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Antibody Discovery Market In 2029?
In recent times, the antibody discovery market has seen substantial growth. The market is projected to expand from $8.96 billion in 2024 to $9.78 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.2%. The surge in investment towards drug discovery, escalating funding in research and development activities, and the existence of numerous healthcare research centers and academic institutions have been key contributors to growth during the historic period.
In the coming years, the size of the antibody discovery market is predicted to witness significant expansion. It is projected to reach $14.31 billion by 2029, with a compound annual growth rate (CAGR) of 10.0%. Factors propelling this growth include a rise in demand for antibody drug discovery services and platforms, increased funding for developing cutting-edge technologies, a growing need for precision therapeutics, and expanded usage of antibodies beyond their traditional therapeutic uses. Key trends for the forecast period encompass escalated research and development efforts, a rising demand for monoclonal antibodies, greater adoption of progressive technologies, increasing need for targeted therapeutics, and the emergence of innovative antibody formats.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Antibody Discovery Market?
The surge in demand for precision therapeutics is set to fuel the expansion of the antibody discovery market. This form of therapeutics, also known as personalized therapeutics, involves tailoring medical treatment and interventions to the unique characteristics of each patient. Antibody discovery plays a major role in precision therapeutics, allowing the creation of targeted treatments, like monoclonal antibodies. These are crafted to interact specifically and accurately with disease-related molecules or cells, enabling a more personalized and efficient treatment plan. For example, in January 2023, the Personalized Medicine Coalition – a professional membership organization in the US, reported that the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) gave approval to 37 new molecular entities (NMEs) in 2022. Of the 35 therapeutic NMEs, approximately 34%, equalling to 12, were identified as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the escalating demand for precision therapeutics will significantly contribute to the growth of the antibody discovery market.
Which Key Market Segments Comprise the Antibody Discovery Market and Drive Its Revenue Growth?
The antibody discovery market covered in this report is segmented –
1) By Methods: Phage Display, Hybridoma, Other Methods
2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody
3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory
Subsegments:
1) By Phage Display: Selection And Screening Techniques, Optimization Methods
2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes
3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13783&type=smp
Which Areas Are Leading Regions in the Antibody Discovery Market Expansion Across the Globe?
North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Strategic Trends Steering theAntibody Discovery Market Direction?
Leading organizations in the antibody discovery market are implementing groundbreaking technology including an AI-powered computational antibody drug discovery platform to refine and enhance the process of antibody development. Such an AI-based platform employs artificial intelligence and computational strategies to accelerate the identification and optimization of therapeutic antibodies. For example, SwiftPharma BV, a company based in Belgium that specializes in the creation of recombinant proteins leveraging a unique plant-based system, unveiled an antibody discovery platform powered by artificial intelligence in October 2023. This trailblazing application consolidates artificial intelligence, vast data, machine learning, and phage display methodologies for rapid and precise prediction of high-specificity and high-affinity antibody-antigen interactions. This process, similar to natural language processing, facilitates multifaceted antibody variations, thereby allowing SwiftPharma to generate extensive antibody libraries in a more efficient manner. This revolutionary system expedites the discovery of potential antibody-based drugs with an unmatched pace.
View the full report here:
https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report
How Is the Antibody Discovery Market Conceptually Defined?
Antibody discovery refers to the process of identifying and developing antibodies, which are proteins produced by the immune system to help defend the body against harmful substances, such as bacteria and viruses. Antibodies, also known as immunoglobulins, play a crucial role in the immune response by recognizing and binding to specific molecules called antigens.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13783
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model